Duration of T4 Suppression in Hyperthyroid Cats Treated Once and Twice Daily with Transdermal Methimazole. (9th February 2013)
- Record Type:
- Journal Article
- Title:
- Duration of T4 Suppression in Hyperthyroid Cats Treated Once and Twice Daily with Transdermal Methimazole. (9th February 2013)
- Main Title:
- Duration of T4 Suppression in Hyperthyroid Cats Treated Once and Twice Daily with Transdermal Methimazole
- Authors:
- Boretti, F.S.
Sieber‐Ruckstuhl, N.S.
Schäfer, S.
Baumgartner, C.
Riond, B.
Hofmann‐Lehmann, R.
Reusch, C.E. - Abstract:
- <abstract abstract-type="main" xml:lang="en" id="jvim12040-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jvim12040-sec-0001" sec-type="section"> <title>Background</title> <p>Transdermal methimazole is an acceptable alternative to oral treatment for hyperthyroid cats. There are, however, no studies evaluating the duration of T4 suppression after transdermal methimazole application. Such information would be valuable for therapeutic monitoring.</p> </sec> <sec id="jvim12040-sec-0002" sec-type="section"> <title>Objective</title> <p>To assess variation in serum T4 concentration in hyperthyroid cats after once‐ and twice‐daily transdermal methimazole administration.</p> </sec> <sec id="jvim12040-sec-0003" sec-type="section"> <title>Animals</title> <p>Twenty client‐owned cats with newly diagnosed hyperthyroidism.</p> </sec> <sec id="jvim12040-sec-0004" sec-type="section"> <title>Methods</title> <p>Methimazole was formulated in a pluronic lecithin organogel‐based vehicle and applied to the pinna of the inner ear at a starting dose of 2.5 mg/cat q12h (BID group, 10 cats) and 5 mg/cat q24h (SID group, 10 cats). One and 3 weeks after starting treatment, T4 concentrations were measured immediately before and every 2 hours after gel application over a period of up to 10 hours.</p> </sec> <sec id="jvim12040-sec-0005" sec-type="section"> <title>Results</title> <p>Significantly decreased T4 concentrations were observed in week 1 and 3 compared with pretreatment<abstract abstract-type="main" xml:lang="en" id="jvim12040-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jvim12040-sec-0001" sec-type="section"> <title>Background</title> <p>Transdermal methimazole is an acceptable alternative to oral treatment for hyperthyroid cats. There are, however, no studies evaluating the duration of T4 suppression after transdermal methimazole application. Such information would be valuable for therapeutic monitoring.</p> </sec> <sec id="jvim12040-sec-0002" sec-type="section"> <title>Objective</title> <p>To assess variation in serum T4 concentration in hyperthyroid cats after once‐ and twice‐daily transdermal methimazole administration.</p> </sec> <sec id="jvim12040-sec-0003" sec-type="section"> <title>Animals</title> <p>Twenty client‐owned cats with newly diagnosed hyperthyroidism.</p> </sec> <sec id="jvim12040-sec-0004" sec-type="section"> <title>Methods</title> <p>Methimazole was formulated in a pluronic lecithin organogel‐based vehicle and applied to the pinna of the inner ear at a starting dose of 2.5 mg/cat q12h (BID group, 10 cats) and 5 mg/cat q24h (SID group, 10 cats). One and 3 weeks after starting treatment, T4 concentrations were measured immediately before and every 2 hours after gel application over a period of up to 10 hours.</p> </sec> <sec id="jvim12040-sec-0005" sec-type="section"> <title>Results</title> <p>Significantly decreased T4 concentrations were observed in week 1 and 3 compared with pretreatment concentrations in both groups. All cats showed sustained suppression of T4 concentration during the 10‐hour period, and T4 concentrations immediately before the next methimazole treatment were not significantly different compared with any time point after application, either in the BID or SID groups.</p> </sec> <sec id="jvim12040-sec-0006" sec-type="section"> <title>Conclusions</title> <p>Because transdermal methimazole application led to prolonged T4 suppression in both the BID and SID groups, timing of blood sampling does not seem to be critical when assessing treatment response.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of veterinary internal medicine. Volume 27:Number 2(2013:Mar./Apr.)
- Journal:
- Journal of veterinary internal medicine
- Issue:
- Volume 27:Number 2(2013:Mar./Apr.)
- Issue Display:
- Volume 27, Issue 2 (2013)
- Year:
- 2013
- Volume:
- 27
- Issue:
- 2
- Issue Sort Value:
- 2013-0027-0002-0000
- Page Start:
- 377
- Page End:
- 381
- Publication Date:
- 2013-02-09
- Subjects:
- Veterinary medicine -- Periodicals
636.0896 - Journal URLs:
- http://www.jvetintmed.org ↗
http://www3.interscience.wiley.com/journal/118902531/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jvim.12040 ↗
- Languages:
- English
- ISSNs:
- 0891-6640
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5072.365000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3434.xml